Registered organisation
Novartis AG
Address space registered to Novartis AG, and where it is announced from.
Registered holders come from the bulk whois that RIPE, APNIC and AFRINIC publish. ARIN and LACNIC do not publish theirs, so holders in North and South America are largely missing here.
IPv4 addresses
651,264
IPv6 /64s
34,359,738,369
Registered blocks
10
Countries
4
What this tells you
- Holds 651,264 IPv4 addresses and 34,359,738,369 IPv6 /64 networks across 10 registered blocks.
- Almost none of this space is announced to the internet: 1% of its IPv4 space appears in the routing table. Space can be held for decades without being used, and a legacy allocation this size is usually one of those.
- Announced by 3 networks, the largest being AS25031 Novartis AG at 0.9% of the IPv4 space.
- Its space resolves to 4 countries, mostly Switzerland (99% of the IPv4 space).
Networks announcing this space
| Network | IPv4 share | |
|---|---|---|
| AS25031 Novartis AG | 0.9% | |
| AS26478 Novartis Pharmaceuticals | 0.2% | |
| Everything else, including space not announced (1 more) | 99% |
Countries this space resolves to
| Country | IPv4 share | IPv6 share | |
|---|---|---|---|
| Switzerland | 99% | 100% | |
| United States | 0.2% | - | |
| Everything else, including space we cannot place (2 more) | 0.1% | - |
Holding a block is a registry fact, not a physical one. The organisation named here is who the block is assigned to, which is often a customer of the network operator announcing it.